跳至主要内容
临床试验/ITMCTR2100004941
ITMCTR2100004941招募中未知

Clinical study on the actual effect of Qishishengjiangguiyuan granule in the treatment of gastroesophageal reflux disease based on the real world

The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 70(—)
性别
All

入选标准

  • 1. Those who meet the diagnostic criteria of GERD;
  • 2. Aged 18 to 70 years;
  • 3. Those who have not participated in other clinical research within 1 month;
  • 4. After sufficient communication, voluntarily participate in this project and sign an informed consent.

排除标准

  • 1. Those who have severe spinal trauma and skin burns;
  • 2. People with severe peptic ulcer, history of gastrointestinal surgery, gastrointestinal space-occupying lesions and other serious complications;
  • 3. Pregnant or lactating women;
  • 4. Patients with severe liver and kidney insufficiency, malignant tumors, who cannot tolerate gastroscopy as assessed by clinicians;
  • 5. People with other diseases such as immunity and organ failure;
  • 6. Merge mental patients who cannot control and may hurt others;
  • 7. Those who have other serious infectious diseases, such as tuberculosis, anti-HIV positive;
  • 8. Patients who have taken medicines (such as Probensine, Belladonna, Atropine, Aminophylline, Niacin, Diazepam, Valium, etc.) that can reduce the tension of the lower esophageal sphincter in the past week.

研究者

相似试验